drugset / Trial / NCT00760461
Domperidone in Refractory Gastroparesis
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to prescribe oral domperidone for patients with gastroparesis who have failed or suffered adverse effects from standard medical therapy.
Timeline
- Start
- 2008-10
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Domperidone | Unknown | 10 mg | Oral |
| Subject | Domperidone | Unknown | 20 mg | Oral |
| Subject | Domperidone | Unknown | 30 mg | Oral |